Coronavirus drug to be tested on patients in Israel
XPOVIO was developed for treating patients with relapsed or refractory multiple myeloma and is already FDA approved for this purpose.
Colorful of tablets and capsules pill in blister packaging arranged with beautiful pattern with flare light. Pharmaceutical industry concept. Pharmacy drugstore. Antibiotic drug resistance(photo credit: INGIMAGE)ByROSSELLA TERCATIN
